Clinical Trials & Research

A research group from the Department of Biochemistry and Molecular Biology of the University of Valencia (UV), in coordination with the National Centre for Biotechnology (CNB) of the CSIC, has studied the role of the interactions within the membrane of proteins of viral families Herpesviridae and Poxviridae in the control of programmed cell death. The
0 Comments
The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, continues to wreak havoc across the globe. Nearly a year on since the virus was first detected in Wuhan, China, in late 2019, over 61.1 million people have been infected across 191 countries, and 1.43 million have
0 Comments
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread like wildfire all over the world. A major contributing factor to SARS-CoV-2’s rapid and worldwide transmission has been international travel. Travelers wear masks at Kuala Lumpur International Airport to prevent infection from coronavirus outbreak. February, 2020. Image Credit:
0 Comments
Image credit: vladwel/Shutterstock.com Subscribe | Spotify | Stitcher | Apple | iHeartRadio | Mobile | Download In recent years webinars have seen a resurgence within many scientific sectors. They form a great platform to bring together technically minded individuals to explore more complex topics. Equipment manufacturers use them as a cost-saving alternative to tradeshows giving
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 20 2020 There is growing evidence that adipose tissue plays a key role in the aggravation of COVID-19. One of the theories under investigation is that fat cells (adipocytes) act as a reservoir for SARS-CoV-2 and increase viral load in obese or overweight individuals. Scientists also suspect that during infection
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 19 2020 Researchers from the University of Alicante (UA) and Alicante General University Hospital’s Institute for Health and Biomedical Research (ISABIAL) have developed a new non-invasive method for diagnosing and preventing colorectal cancer (CRC) through the analysis of volatile organic compounds in stool samples. It is worth noting that over
0 Comments
While vaccine candidates undergo clinical trials or await regulatory body approval, non-pharmaceutical interventions (NPIs) aimed at reducing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen for the coronavirus disease 2019 (COVID-19) pandemic, has been the dominant approach of most countries around the world. These NPIs have mostly entailed government-led behavioral
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 16 2020 Researchers identify a region of the brain as a key source of signals encoding past experiences in the neocortex. The brain encodes information collected by our senses. In order to perceive and interact with the environment, however, these sensory signals must be interpreted in the context of past
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 12 2020 New research from the University of Cincinnati (UC) finds that women with kidney failure have low rates of contraceptive use. The study, published in the journal Kidney Medicine, finds an overall contraceptive use rate of 5.3% among women with kidney failure undergoing dialysis in the United States. Although
0 Comments
Nov 12 2020 MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus’s ability to replicate itself and stimulate the host cell’s inflammation response. If researchers could devise ways to block
0 Comments
Nov 13 2020 Porvair Sciences reports, due to promising results, it has agreed with its collaborative partners to make additional investment in the CEAT project** which aims to dramatically improve the diagnosis and treatment of ovarian cancer. In the initial stage of the CEAT (Cluster for Epigenomic and Antibody Drug Conjugate Therapeutics) project – Porvair
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 9 2020 Using neighborhood and local data in combination with existing information sources creates a more accurate prediction on a patient’s recovery prospects after an out-of-hospital cardiac arrest (OHCA), according to preliminary research to be presented at the American Heart Association’s Resuscitation Science Symposium 2020. The 2020 meeting will be
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 6 2020 The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study. The study was presented at the virtual annual meeting of the American College
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 6 2020 A new study has shown pregnant women with obesity could reduce the health risks for their infants through improved diet and more physical activity. Research published today in the journal PLosMed investigates the impact of high glucose in mothers with gestational diabetes mellitus (GDM) and changes to infants
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 6 2020 A genetically edited form of a herpes simplex virus — rewired to keep it from taking refuge in the nervous system and eluding an immune response — has outperformed a leading vaccine candidate in a new study from the University of Cincinnati, Northwestern University and the University of
0 Comments
Nov 2 2020 Researchers have developed a novel allergen-depleted and anti-inflammatory fragrance that can be used in moisturizers for people with extremely dry, xerotic skin. Beiersdorf researchers in Germany report the results of two tests proving the fragrance is anti-inflammatory at today’s 29th EADV Congress, EADV Virtual. Tests on skin cells found that the anti-inflammatory
0 Comments